These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25378574)

  • 1. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods.
    Quer J; Gregori J; Rodríguez-Frias F; Buti M; Madejon A; Perez-del-Pulgar S; Garcia-Cehic D; Casillas R; Blasi M; Homs M; Tabernero D; Alvarez-Tejado M; Muñoz JM; Cubero M; Caballero A; del Campo JA; Domingo E; Belmonte I; Nieto L; Lens S; Muñoz-de-Rueda P; Sanz-Cameno P; Sauleda S; Bes M; Gomez J; Briones C; Perales C; Sheldon J; Castells L; Viladomiu L; Salmeron J; Ruiz-Extremera A; Quiles-Pérez R; Moreno-Otero R; López-Rodríguez R; Allende H; Romero-Gómez M; Guardia J; Esteban R; Garcia-Samaniego J; Forns X; Esteban JI
    J Clin Microbiol; 2015 Jan; 53(1):219-26. PubMed ID: 25378574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-Deep Sequencing Characterization of HCV Samples with Equivocal Typing Results Determined with a Commercial Assay.
    Minosse C; Giombini E; Bartolini B; Capobianchi MR; Garbuglia AR
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27739414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses.
    Welzel TM; Bhardwaj N; Hedskog C; Chodavarapu K; Camus G; McNally J; Brainard D; Miller MD; Mo H; Svarovskaia E; Jacobson I; Zeuzem S; Agarwal K
    J Hepatol; 2017 Aug; 67(2):224-236. PubMed ID: 28343981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice.
    González V; Gomes-Fernandes M; Bascuñana E; Casanovas S; Saludes V; Jordana-Lluch E; Matas L; Ausina V; Martró E
    J Clin Virol; 2013 Sep; 58(1):249-53. PubMed ID: 23731847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two unusual hepatitis C virus subtypes, 2j and 2q, in Spain: Identification by nested-PCR and sequencing of a NS5B region.
    Margall N; March F; Español M; Torras X; Gallego A; Coll P
    J Virol Methods; 2015 Oct; 223():105-8. PubMed ID: 26253334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test.
    Mokhtari C; Ebel A; Reinhardt B; Merlin S; Proust S; Roque-Afonso AM
    J Clin Microbiol; 2016 Feb; 54(2):296-9. PubMed ID: 26582834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indeterminate Prediction of Hepatitis C Virus Genotype by Commercial Real-Time Polymerase Chain Reaction Assay Resolving by Sequencing to Avoid the Consequence of Inaccurate Typing.
    Aziz H; Fatima S; Faheem M
    Viral Immunol; 2020 Sep; 33(7):507-513. PubMed ID: 32429831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience.
    Del Campo JA; Parra-Sánchez M; Figueruela B; García-Rey S; Quer J; Gregori J; Bernal S; Grande L; Palomares JC; Romero-Gómez M
    Int J Infect Dis; 2018 Feb; 67():114-117. PubMed ID: 29253705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel next generation sequencing assay as an alternative to currently available methods for hepatitis C virus genotyping.
    Dirani G; Paesini E; Mascetra E; Farabegoli P; Dalmo B; Bartolini B; Garbuglia AR; Capobianchi MR; Sambri V
    J Virol Methods; 2018 Jan; 251():88-91. PubMed ID: 29045810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination.
    Rodriguez C; Soulier A; Demontant V; Poiteau L; Mercier-Darty M; Bouvier-Alias M; Pawlotsky JM; Chevaliez S
    Sci Rep; 2018 Mar; 8(1):4180. PubMed ID: 29520035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay.
    Saludes V; Antuori A; Reinhardt B; Viciana I; Clavijo E; Schreiber L; Tenenbaum M; Rodriguez-Frias F; Quer J; Matas L; Martró E
    Sci Rep; 2019 Mar; 9(1):3678. PubMed ID: 30842623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Abbott realtime HCV genotype II RUO (GT II) assay with reference to 5'UTR, core and NS5B sequencing.
    Mallory MA; Lucic DX; Sears MT; Cloherty GA; Hillyard DR
    J Clin Virol; 2014 May; 60(1):22-6. PubMed ID: 24656214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate genotyping of hepatitis C virus through nucleotide sequencing and identification of new HCV subtypes in China population.
    Tong YQ; Liu B; Liu H; Zheng HY; Gu J; Liu H; Song EJ; Song C; Li Y
    Clin Microbiol Infect; 2015 Sep; 21(9):874.e9-874.e21. PubMed ID: 26055416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of the VERSANT HCV genotype 2.0 assay.
    Yang R; Wei L
    Expert Rev Mol Diagn; 2018 Dec; 18(12):995-1004. PubMed ID: 30372355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital.
    Goletti S; Zuyten S; Goeminne L; Verhofstede C; Rodriguez-Villalobos H; Bodeus M; Stärkel P; Horsmans Y; Kabamba-Mukadi B
    BMC Infect Dis; 2019 Aug; 19(1):738. PubMed ID: 31438880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b.
    Neukam K; Martínez AP; Culasso ACA; Ridruejo E; García G; Di Lello FA
    PLoS One; 2017; 12(7):e0182193. PubMed ID: 28753662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing.
    Mallory MA; Lucic D; Ebbert MT; Cloherty GA; Toolsie D; Hillyard DR
    J Clin Virol; 2017 May; 90():26-31. PubMed ID: 28324789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping hepatitis C virus from hemodialysis patients in Central Brazil by line probe assay and sequence analysis.
    Espírito-Santo MP; Carneiro MA; Reis NR; Kozlowski AG; Teles SA; Lampe E; Yoshida CF; Martins RM
    Braz J Med Biol Res; 2007 Apr; 40(4):545-50. PubMed ID: 17401498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico.
    Uribe-Noguez LA; Mata-Marín JA; Ocaña-Mondragón A; Pompa-Mera EN; Ribas-Aparicio RM; Arroyo-Anduiza CI; Gomez-Torres ME; Chaparro-Sánchez A; Gaytán-Martínez J; Mauss S
    J Infect Chemother; 2020 Feb; 26(2):205-210. PubMed ID: 31537472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance assessment of a fully automated deep sequencing platform for HCV resistance testing.
    Rodriguez C; Mercier-Darty M; Soulier A; Poiteau L; Wlassow M; Fourati S; Hézode C; Pawlotsky JM; Chevaliez S
    Antivir Ther; 2019; 24(6):417-423. PubMed ID: 31112134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.